HRT Financial’s HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant HHLA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-109,053
Closed -$1.08M 3414
2022
Q3
$1.08M Hold
109,053
0.01% 863
2022
Q2
$1.08M Hold
109,053
0.01% 868
2022
Q1
$1.08M Hold
109,053
0.01% 969
2021
Q4
$1.09M Hold
109,053
0.01% 1040
2021
Q3
$1.08M Sell
109,053
-2,464
-2% -$24.6K 0.01% 1188
2021
Q2
$1.13M Buy
111,517
+4,064
+4% +$41.1K 0.01% 947
2021
Q1
$1.08M Buy
+107,453
New +$1.11M 0.01% 1041

Other funds holding HHLA.U

HRT Financial's HHLA.U Position: Q4 2022 in Review

HRT Financial sold out of HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (HHLA.U) in Q4 2022, closing a stake of 109,053 shares — an estimated $1.08M sold.

HRT Financial first reported a position in HHLA.U in Q1 2021 and held it in 7 quarters. The position peaked at $1.13M in Q2 2021. 13 funds tracked by Wall St. Rank hold HHLA.U as of Q4 2022.

  • HRT Financial reported no remaining HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 109,053 HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q4 2022, an estimated $1.08M.
  • HRT Financial first reported a position in HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • HRT Financial's HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $1.13M in Q2 2021.
  • 13 funds tracked by Wall St. Rank held HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.